Fetal Membranes, Premature Rupture
1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Pediatrix TherapeuticsRetention of Cerclage
Labcorpnon- intervention study
Clinical Trials (2)
Total enrollment: 658 patients across 2 trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Start: Nov 2004Est. completion: Apr 201458 patients
Phase 4Terminated
PROMComplete for Determination of Rupture of Fetal Membranes
Start: Aug 2015Est. completion: Dec 2018600 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.